Central Nervous System Pharmacology Practice Questions

Q: Which of the following substances exhibits an increased tendency to promote sleep without causing central nervous system depression?

Melatonin. **Explanation:** **Melatonin** is the correct answer because it is a naturally occurring hormone produced by the pineal gland that regulates the **circadian rhythm** (sleep-wake cycle). Unlike traditional sedatives (like benzodiazepines or barbiturates), melatonin promotes sleep by signaling the "biological night" to the brain via **MT1 and MT2 receptors** in the suprachiasmatic nucleus. It facilitates sleep onset without causing generalized CNS depression, respiratory depression, or significant cognitive impairment. **Analysis of Incorrect Options:** * **Pyridoxine (Vitamin B6):** While it is a cofactor in the synthesis of neurotransmitters like GABA and serotonin, it does not have direct sedative properties. In fact, high doses taken at night may occasionally cause vivid dreams or restlessness. * **Diphenhydramine:** This is a first-generation H1-antihistamine. While it promotes sleep, it does so by crossing the blood-brain barrier and causing **significant CNS depression**, leading to side effects like daytime drowsiness, impaired psychomotor function, and anticholinergic effects. * **Ethanol:** Although it shortens sleep latency, ethanol is a potent **CNS depressant**. It disrupts sleep architecture (reducing REM sleep) and can lead to rebound insomnia and respiratory depression. **NEET-PG High-Yield Pearls:** * **Ramelteon:** A synthetic MT1/MT2 receptor agonist used for insomnia; it has no abuse potential and is not a controlled substance. * **Suvorexant:** An **Orexin receptor antagonist** (Dual Orexin Receptor Antagonist - DORA), another class of sleep aids that promotes sleep by inhibiting wakefulness rather than inducing global CNS depression. * Melatonin is specifically indicated for **Jet Lag** and **Delayed Sleep Phase Disorder**.

Q: Which of the following is a selective 5-HT1B/1D receptor agonist useful in the acute management of migraine?

Frovatriptan. ### Explanation **Correct Answer: C. Frovatriptan** **Mechanism and Rationale:** Triptans (like Frovatriptan, Sumatriptan, and Rizatriptan) are the first-line agents for the **acute management** of moderate-to-severe migraine attacks. They act as selective agonists at **5-HT1B** and **5-HT1D** receptors. * **5-HT1B stimulation** causes vasoconstriction of dilated intracranial extracerebral blood vessels. * **5-HT1D stimulation** acts on trigeminal nerve endings to inhibit the release of pro-inflammatory neuropeptides (like CGRP and Substance P), thereby blocking neurogenic inflammation. **Analysis of Incorrect Options:** * **A. Buspirone:** A selective **5-HT1A partial agonist** used primarily as a non-benzodiazepine anxiolytic for Generalized Anxiety Disorder (GAD). It has no role in migraine management. * **B. Ondansetron:** A **5-HT3 receptor antagonist** used as a potent antiemetic, particularly for chemotherapy-induced nausea and vomiting (CINV). * **D. Ketanserin:** A **5-HT2 receptor antagonist** (with α1-blocking properties) used occasionally as an antihypertensive; it is not used for migraine. **High-Yield NEET-PG Pearls:** * **Longest Half-life:** Frovatriptan has the longest half-life (~26 hours) among all triptans, making it ideal for preventing **menstrual migraine** and reducing recurrence. * **Fastest Acting:** Sumatriptan (SC) or Rizatriptan (Oral). * **Contraindications:** Due to their vasoconstrictive properties, triptans are strictly contraindicated in patients with **Ischemic Heart Disease (IHD)**, Prinzmetal angina, or uncontrolled hypertension. * **Serotonin Syndrome:** Risk increases if triptans are co-administered with SSRIs or MAO inhibitors.

Q: Benzodiazepines exert their effects through which receptor subtype?

GABA-A. **Explanation:** **Benzodiazepines (BZDs)** act as positive allosteric modulators of the **GABA-A receptor**. This receptor is a ligand-gated ionotropic chloride channel. When BZDs bind to a specific site (the BZD site, located between the $\alpha$ and $\gamma$ subunits), they increase the **frequency** of chloride channel opening in response to GABA. This leads to hyperpolarization of the postsynaptic neuron, resulting in CNS depression (anxiolysis, sedation, and anticonvulsant effects). **Analysis of Options:** * **GABA-A (Correct):** It is an **ionotropic** receptor. BZDs increase the frequency of channel opening, while Barbiturates increase the duration. * **GABA-B (Incorrect):** This is a **metabotropic** (G-protein coupled) receptor linked to $K^+$ channels. It is the target for **Baclofen**, a centrally acting muscle relaxant. BZDs have no affinity for this receptor. * **GABA-C (Incorrect):** Now often classified as a subtype of GABA-A ($\rho$ subunits), these are found primarily in the retina and are not the target for standard BZDs. * **GABA-D (Incorrect):** There is no medically recognized GABA-D receptor subtype. **High-Yield Clinical Pearls for NEET-PG:** 1. **Antidote:** **Flumazenil** is a competitive antagonist at the BZD binding site on the GABA-A receptor, used to reverse BZD overdose. 2. **Z-drugs:** Zolpidem, Zaleplon, and Eszopiclone also bind to the GABA-A receptor (specifically the $\alpha_1$ subunit) but are chemically distinct from BZDs. 3. **Mechanism Distinction:** Remember the mnemonic: **"Fre-zzy"** (BZD increases **Fre**quency) and **"Du-bar"** (Barbiturates increase **Du**ration).

Q: Which of the following is NOT a long-established antiepileptic drug used in complex partial seizures?

Lamotrigine. **Explanation:** The classification of antiepileptic drugs (AEDs) is historically divided into **Older (First-generation)** and **Newer (Second-generation)** agents. This distinction is high-yield for NEET-PG as it dictates side-effect profiles and pharmacokinetic properties. **Why Lamotrigine is the correct answer:** Lamotrigine is classified as a **Newer (Second-generation) AED**, introduced in the 1990s. While it is highly effective for focal (complex partial) seizures and Lennox-Gastaut syndrome, it is not considered a "long-established" or "older" drug compared to the other options. **Analysis of Incorrect Options:** * **Carbamazepine:** Long considered the traditional **drug of choice (DOC)** for complex partial seizures. It is a classic sodium channel blocker and a prototype of the older generation. * **Phenytoin:** One of the oldest AEDs (introduced in 1938). It is a first-line agent for focal and generalized tonic-clonic seizures, known for its zero-order kinetics at high doses. * **Valproate:** A broad-spectrum older AED effective against almost all seizure types, including complex partial seizures, by enhancing GABAergic transmission and blocking sodium/T-type calcium channels. **High-Yield Clinical Pearls for NEET-PG:** * **Lamotrigine Side Effect:** Watch for **Stevens-Johnson Syndrome (SJS)**; the dose must be titrated slowly to minimize this risk. * **Drug of Choice:** While Carbamazepine was the traditional DOC for complex partial seizures, newer guidelines often favor **Levetiracetam** or **Lamotrigine** due to better tolerability and fewer drug interactions. * **Enzyme Induction:** Phenytoin and Carbamazepine are potent **enzyme inducers**, whereas Valproate is an **enzyme inhibitor**. Lamotrigine is metabolically neutral but its levels are doubled when co-administered with Valproate.

Q: Felbamate is used in the treatment of which condition?

Epilepsy. **Explanation:** **Felbamate** is a potent anticonvulsant medication primarily used in the management of **Epilepsy**. Its mechanism of action is unique and multi-modal: it acts as a potent antagonist at the glycine-binding site of the **NMDA (N-methyl-D-aspartate) receptor**, thereby inhibiting excitatory neurotransmission. It also modulates GABA-A receptors and blocks voltage-gated sodium channels. * **Why Option A is correct:** Felbamate is specifically indicated for refractory partial seizures in adults and as an adjunctive treatment for **Lennox-Gastaut Syndrome** (a severe childhood-onset epilepsy) in children. * **Why Options B, C, and D are incorrect:** While some antiepileptics (like Pregabalin for anxiety or SSRIs for depression/social phobia) have cross-over uses in psychiatry, Felbamate has no clinical role in treating Anxiety, Social Phobia, or Depression. Its severe side-effect profile limits its use strictly to intractable epilepsy. **High-Yield Clinical Pearls for NEET-PG:** * **Black Box Warning:** Felbamate is notorious for two life-threatening adverse effects: **Aplastic Anemia** and **Acute Hepatic Failure**. * **Clinical Utility:** Due to these toxicities, it is considered a **third-line drug**, reserved only for patients who do not respond to other medications and where the benefit of seizure control outweighs the risk of bone marrow or liver failure. * **Monitoring:** Patients on Felbamate require frequent monitoring of Complete Blood Count (CBC) and Liver Function Tests (LFTs).

Q: Which of the following nerve fibers is most sensitive to inhibition by local anesthetics?

B fiber. The sensitivity of nerve fibers to local anesthetics (LAs) is determined by fiber diameter, myelination, and the length of the fiber exposed to the drug. **Explanation of the Correct Answer:** **B fibers** are preganglionic autonomic fibers. Although they are slightly larger than C fibers, they are **myelinated**. Myelination makes them highly susceptible to local anesthetics because the drug only needs to block the sodium channels at the Nodes of Ranvier. In clinical practice, B fibers are the first to be blocked during spinal or epidural anesthesia, which explains why **sympathetic blockade** (vasodilation and hypotension) precedes sensory and motor loss. **Analysis of Incorrect Options:** * **A delta fibers:** These are small, myelinated fibers responsible for fast pain and temperature. While sensitive, they are blocked after B fibers. * **A alpha fibers:** These are the largest, heavily myelinated motor and proprioception fibers. Due to their large diameter, they are the **most resistant** to local anesthetics and are the last to be blocked. * **Dorsal root:** This is an anatomical structure containing various fiber types (A delta, C, etc.) rather than a specific fiber classification. **High-Yield Clinical Pearls for NEET-PG:** * **Order of Blockade (Clinical):** Autonomic (B) > Pain/Temperature (Aδ, C) > Touch/Pressure (Aβ) > Motor (Aα). * **The "C-fiber" Paradox:** Although C fibers are the smallest, they are unmyelinated. Myelinated B and Aδ fibers are often blocked faster because the anesthetic concentrates at the nodes. * **Differential Block:** This is the clinical phenomenon where different nerve functions are lost at different concentrations/times. Sympathetic block is typically 2–3 segments higher than sensory block in spinal anesthesia.

Q: Which of the following vitamins should not be supplemented in a patient with parkinsonism on levodopa therapy?

Pyridoxine. **Explanation:** **1. Why Pyridoxine (Vitamin B6) is the correct answer:** Levodopa is a precursor to dopamine that must cross the blood-brain barrier (BBB) to be effective. However, it is susceptible to **peripheral decarboxylation** by the enzyme **DOPA decarboxylase**. Pyridoxine acts as a vital **cofactor** for this enzyme. When a patient takes supplemental Pyridoxine, it accelerates the peripheral conversion of Levodopa into Dopamine. Since Dopamine cannot cross the BBB, this leads to two negative outcomes: * **Reduced Efficacy:** Less Levodopa reaches the brain, worsening parkinsonian symptoms. * **Increased Side Effects:** High levels of peripheral dopamine cause systemic effects like nausea, vomiting, and cardiac arrhythmias. *Note: This interaction is only clinically significant when Levodopa is used alone. If Levodopa is combined with a peripheral decarboxylase inhibitor like **Carbidopa**, this interaction is largely abolished.* **2. Why other options are incorrect:** * **Thiamine (B1), Cobalamine (B12), and Pantothenic acid (B5):** These vitamins do not serve as cofactors for DOPA decarboxylase. They do not interfere with the pharmacokinetics or pharmacodynamics of Levodopa and are safe to supplement if clinically indicated. **3. NEET-PG High-Yield Pearls:** * **The "Carbidopa" Rule:** Carbidopa does not cross the BBB; it inhibits peripheral decarboxylation, thereby increasing the half-life of Levodopa and allowing for a 75% dose reduction. * **Vitamin B6 & Levodopa:** This is a classic "Drug-Vitamin Interaction." * **Dietary Tip:** Patients on Levodopa should also avoid high-protein meals simultaneously with their medication, as neutral amino acids compete with Levodopa for transport across the BBB.

Q: Which of the following is NOT a side effect of phenytoin?

Microcytic anemia. **Explanation:** Phenytoin is a widely used antiepileptic drug known for its narrow therapeutic index and a distinct profile of side effects. **Why Microcytic Anemia is the Correct Answer:** Phenytoin does **not** cause microcytic anemia. Instead, it is characteristically associated with **Megaloblastic Anemia** (a type of macrocytic anemia). This occurs because phenytoin interferes with the absorption and metabolism of dietary folate, leading to folate deficiency. **Analysis of Incorrect Options:** * **A. Gum Hypertrophy:** This is a classic side effect occurring in about 20% of patients. It is caused by the overgrowth of gingival tissue due to increased expression of platelet-derived growth factor (PDGF). * **B. Hirsutism:** Phenytoin can cause excessive hair growth, particularly in young females, making it a less desirable choice for this demographic. * **C. Osteomalacia:** Phenytoin induces hepatic microsomal enzymes (CYP450), which increases the metabolism of Vitamin D. This leads to hypocalcemia and secondary hyperparathyroidism, resulting in osteomalacia (softening of bones). **High-Yield Clinical Pearls for NEET-PG:** To remember Phenytoin side effects, use the mnemonic **"HOT MALAI"**: * **H** – Hirsutism, Hypertrophy of gums * **O** – Osteomalacia * **T** – Teratogenicity (Fetal Hydantoin Syndrome: cleft lip/palate, digital hypoplasia) * **M** – Megaloblastic anemia * **A** – Ataxia * **L** – Lymphadenopathy (Pseudolymphoma) * **A** – Arrhythmias (on rapid IV injection) * **I** – Insulin inhibition (leading to hyperglycemia) **Note:** Phenytoin follows **Zero-order kinetics** (saturation kinetics) at therapeutic concentrations, meaning a small dose increase can lead to a disproportionate rise in plasma levels and toxicity.

Question 1

Which of the following substances exhibits an increased tendency to promote sleep without causing central nervous system depression?

Accepted Answer

Melatonin

Answer

Pyridoxine

Answer

Diphenhydramine

Answer

Ethanol

Question 2

Which of the following is a selective 5-HT1B/1D receptor agonist useful in the acute management of migraine?

Accepted Answer

Frovatriptan

Answer

Buspirone

Answer

Ondansetron

Answer

Ketanserin

Question 3

Benzodiazepines exert their effects through which receptor subtype?

Accepted Answer

GABA-A

Answer

GABA-B

Answer

GABA-C

Answer

GABA-D

Question 4

Which of the following is NOT a long-established antiepileptic drug used in complex partial seizures?

Accepted Answer

Lamotrigine

Answer

Valproate

Answer

Carbamazepine

Answer

Phenytoin

Question 5

Felbamate is used in the treatment of which condition?

Accepted Answer

Epilepsy

Answer

Anxiety

Answer

Social phobia

Answer

Depression

Question 6

Which of the following nerve fibers is most sensitive to inhibition by local anesthetics?

Accepted Answer

B fiber

Answer

Dorsal root

Answer

A delta fiber

Answer

A alpha fiber

Question 7

Which of the following vitamins should not be supplemented in a patient with parkinsonism on levodopa therapy?

Accepted Answer

Pyridoxine

Answer

Thiamine

Answer

Cobalamine

Answer

Pantothenic acid

Question 8

Which of the following is NOT a side effect of phenytoin?

Accepted Answer

Microcytic anemia

Answer

Gum hypertrophy

Answer

Hirsutism

Answer

Osteomalacia

Question 9

Which anticonvulsive agent would be MOST appropriate as first-line therapy for a 21-year-old woman recently diagnosed with complex partial seizures?

Accepted Answer

Lamotrigine

Answer

Carbamazepine

Answer

Topiramate

Answer

Phenytoin

Question 10

Which statement is true regarding morphine?

Accepted Answer

Tolerance develops for all effects except miosis and constipation.

Answer

Tolerance to all effects develops with chronic usage.

Answer

Tolerance develops for all effects except euphoria and sedation.

Answer

Tolerance can develop to all effects in high doses.

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?